Elanco Animal Health Incorporated (ELAN) EPS by Year
ELANNYSE
Elanco Animal Health Incorporated lost $0.47 per diluted share in fiscal year 2025. This represents a decrease of 169.1% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to a loss of $0.30 per diluted share. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Elanco Animal Health Incorporated has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Elanco Animal Health Incorporated lost $0.47 per diluted share in fiscal year 2025.
Elanco Animal Health Incorporated (ELAN) diluted earnings per share fell by 169.1% year over year, from $0.68 to -$0.47 in fiscal year 2025.
Elanco Animal Health Incorporated (ELAN) reported a loss of $0.30 per diluted share over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Across the 10 fiscal years this page covers, Elanco Animal Health Incorporated (ELAN) diluted earnings per share went from -$0.16 in fiscal year 2016 to -$0.47 in fiscal year 2025.
Elanco Animal Health Incorporated (ELAN) reported $0.04 in diluted earnings per share in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Elanco Animal Health Incorporated (ELAN) reported on that line in every period on record.